Distinct features of circulating microparticles and their relationship with disease activity in inflammatory bowel disease
(EN)
Karmiris, Konstantinos
Sfridaki, Aekaterini
Vetsika, Eleni-Kyriaki
Voudoukis, Evangelos
Giannakopoulou, Konstantina
Theodoropoulou, Angeliki
Paspatis, Gregorios A.
Koutroubakis, Ioannis E.
Georgoulias, Vassilis
Background There is evidence that circulating microparticles (MPs) and annexin (+) platelet-derived MPs (PDMPs) are increased in inflammatory bowel disease (IBD). The aim of our study was to characterize the abundance, origin, and annexin V binding of MPs in patients with IBD and correlate them with the disease characteristics.Methods Case-control study of 46 IBD patients (23 Crohn's disease, 23 ulcerative colitis) and 40 matched healthy controls (HC). MPs were divided according to annexin V binding, their origin was estimated based on specific cell membrane markers in plasma samples and their number was calculated via flow cytometry. Clinical and laboratory activity indices were also analyzed.Results Annexin (-) PDMPs (P=0.0004), total (P=0.04) and annexin (+) monocyte-derived MPs (P=0.02) were increased and annexin (-) total MPs (P=0.0007) were decreased in IBD patients compared to HC. The annexin (+)/(-) ratio of all MP types were significantly elevated in IBD patients compared to HC (P<0.003). IBD patients with active disease displayed elevated total and annexin (+) total MPs, total, annexin (+) and (-) PDMPs compared with those in remission (P<0.05). Annexin (-) PDMPs were considerably increased in IBD patients with active compared to those with inactive disease (P=0.0013). Total and annexin (-) PDMPs were significantly correlated with most of the disease activity indices (P<0.05).Conclusion The majority of circulating MPs, their counterparts and particularly annexin (-) PDMPs are increased in active IBD patients. Annexin (+)/(-) ratio proved to be the most reliable distinctive MP index between HC and IBD patients.Keywords Microparticles, inflammatory bowel disease, Crohn's disease, ulcerative colitisAnn Gastroenterol 2016; 29 (2): 180-187DOI: http://dx.doi.org/10.20524/aog.2016.0010
(EN)
